Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matteo Leoncin
Observed names:
Leoncin M,
M. Leoncin,
Matteo Leocin
Institution:
Ospedale dell' Angelo
Observed institutions:
The University of Texas MD Anderson Cancer Center,
University of Padua,
Veneto Institute of Molecular Medicine,
Ospedale dell' Angelo,
Azienda Ospedale - Università Padova
ORCID:
0000-0002-9677-1250
Observed ORCID:
0000-0002-9677-1250
OpenAlex ID:
A5026857684
STAT3 mutation impacts biological and clinical features of T-LGL leukemia
2017
·
Antonella Teramo
, Gregorio Barilà
, et al.
·
Oncotarget
·
84
PDF
Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients
2019
·
Gregorio Barilà
, Antonella Teramo
, et al.
·
Leukemia
·
77
Lymphoblastic Lymphoma: a Concise Review
2022
·
Tamara Intermesoli
, Alessandra Weber
, et al.
·
Current Oncology Reports
·
57
Up-front blinatumomab improves MRD clearance and outcome in adult Ph– B-lineage ALL: the GIMEMA LAL2317 phase 2 study
2025
·
Renato Bassan
, Sabina Chiaretti
, et al.
·
Blood
·
51
PDF
Efficacy and Toxicity of Frontline Ponatinib Plus Blinatumomab for Adult Ph+ ALL Patients of All Ages. Intermediate Analysis of the Gimema ALL2820
2024
·
Sabina Chiaretti
, Matteo Leoncin
, et al.
·
Blood
·
37
Identification of a miR-146b -Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia
2019
·
Barbara Mariotti
, Giulia Calabretto
, et al.
·
Haematologica
·
35
PDF
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience
2022
·
Eleonora De Bellis
, Silvia Imbergamo
, et al.
·
Leukemia Research
·
33
PDF
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
2023
·
Davide Lazzarotto
, Ilaria Tanasi
, et al.
·
Annals of Hematology
·
25
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
2018
·
Gregorio Barilà
, Antonella Teramo
, et al.
·
Blood Cancer Journal
·
25
PDF
Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial
2023
·
Sabina Chiaretti
, Matteo Leoncin
, et al.
·
Blood
·
17
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience
2024
·
Francesco Angotzi
, Federica Lessi
, et al.
·
Frontiers in Oncology
·
12
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
2021
·
Manuela Tosi
, Orietta Spinelli
, et al.
·
Cancers
·
11
PDF
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study
2024
·
Davide Lazzarotto
, Marco Cerrano
, et al.
·
Haematologica
·
10
PDF
Large Granular Lymphocyte Leukemia and Precapillary Pulmonary Hypertension
2020
·
Brieuc Cherel
, Marc Humbert
, et al.
·
CHEST Journal
·
9
PDF
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
2022
·
Giuliana Rizzuto
, Matteo Leoncin
, et al.
·
Clinical Case Reports
·
8
PDF
Deregulation of FOXF1 / FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia
2026
·
Danika Di Giacomo
, Petri Pölönen
, et al.
·
Blood
·
5
PDF
Tyrosine Kinase Inhibitor (TKI) Discontinuation in Non-Allografted Ph+ Acute Lymphoblastic Leukemia Patients, a Campus ALL Real-Life Study
2023
·
Matteo Dragani
, Roberta Agrippino
, et al.
·
Blood
·
5
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine
2022
·
Matteo Leoncin
, Roberta La Starza
, et al.
·
Current Opinion in Oncology
·
5
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group
2022
·
Marzia Defina
, Davide Lazzarotto
, et al.
·
Leukemia Research
·
4
Diffusion Weighted Whole Body MRI for Evaluation of Early Response in Multiple Myeloma
2017
·
Renato Zambello
, Gregorio Barilà
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
4
Ponatinib–Blinatumomab or Imatinib–Chemotherapy for Adult Ph-Positive ALL
2026
·
Sabina Chiaretti
, Alfonso Piciocchi
, et al.
·
New England Journal of Medicine
·
2
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group
2025
·
Davide Lazzarotto
, Anna Maria Testi
, et al.
·
Annals of Hematology
·
2
PDF
Final Analysis of the Italian Campus ALL Observational Study on 476 Older Patients with Philadelphia-Negative Acute Lymphoblastic Leukemia
2024
·
Marco Cerrano
, Lazzarotto Davide
, et al.
·
Blood
·
2
Real-life management of 476 older adults with Philadelphianegative acute lymphoblastic leukemia: a Campus ALL study
2026
·
Marco Cerrano
, Davide Lazzarotto
, et al.
·
Haematologica
·
1
PDF
Efficacy and safety of a retreatment with inotuzumab ozogamicin in adult patients with relapsed/refractory acute lymphoblastic leukemia: A Campus ALL study
2025
·
Gianluca Cavallaro
, Ferdinando Porretto
, et al.
·
Blood
·
1
PDF
Show more works
View as search
Works count:
51
Citation count:
527
H-index:
11
I10-index:
13
Year
Topic
Type
